Chinese Community Sample of Hierarchical Model of Psychopathology
Condition(s) studied
Investigational drug(s) / intervention(s)
No intervention: cross sectional study#no intervention
Study summary
By validating Hierarchy Model of psychopathology(HiTOP) in Chinese community samples, this study aims for illumating the problem of diagnostic heterogeneity and high comorbidity within existing psychiatric classification systems in Chinese culture. Concurrently, this study also focuses on exploring trans-diagonostic risk and proctective factors underline HiTOP dimensions.
the main questions it aims to answer are:
1. Explore HiTOP model cultural differences between western culture and eastern culture.
2. Understand the impact of different dimension of adverse childhood experience on HiTOP structure.
3. Investigate the relationship between individual unique psychological variables and psychopathological dimensions.
Participants will receive a detailed survey trying to measure their psychopathology symptoms, adverse childhood experience and psychological variables. This study expects to fallow up participants for 4 years to monitor the symptom changes.
Eligibility
Primary outcome measure(s)
- Chinese version of Hierarchy Model of psychopathology — 1 year
Constructing the Chinese version of Hierarchy Model of psychopathology. Comparing the differences between Chinese version and western version. - Mapping different dimension of adverse childhood experience on Hierarchy Model of psychopathology structure — 1 year
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Shanghai Mental Health Center | Shanghai | China | Recruiting |
More Shanghai Mental Health Center trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06105970 on ClinicalTrials.gov ↗ ← All trials in China